Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · IPHC 2027

Cancer at IPHC 2027

Part of the IPHC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Cancer Session

A set of illnesses known as cancer include abnormal cell proliferation and have the ability to infiltrate or spread to different bodily regions. These stand in contrast to benign tumours, which remain stationary. A lump, unusual bleeding, a persistent cough, unexplained weight loss, and a change in bowel habits are all potential warning signs and symptoms. These signs of cancer may be present, but there may be other reasons as well. Humans are susceptible to over 100 different malignancies. About 22% of cancer fatalities are related to tobacco usage. Another 10% of cases are brought on by obesity, a bad diet, a lack of exercise, or excessive alcohol consumption. Other concerns include exposure to ionising radiation, certain diseases, and environmental contaminants. Infections including Helicobacter pylori, hepatitis B, hepatitis C, human papillomavirus infection, Epstein-Barr virus, and human immunodeficiency virus account for 15% of cancer cases in underdeveloped countries (HIV). These elements influence a cell's genes, at least in part. Before cancer manifests, several genetic alterations are often necessary. 5–10%–of malignancies are brought on by inherited genetic flaws. A few warning signs and symptoms as well as screening tests can help diagnose cancer. Medical imaging is typically used to conduct additional research, followed by biopsy for confirmation.

Topics Covered in Cancer

Topic 01

Tumour biology and carcinogenesis

Topic 02

Cancer screening and early detection

Topic 03

Infection-related and viral cancers

Topic 04

Tobacco, alcohol and lifestyle risk factors

Topic 05

Hereditary cancer syndromes and genetic testing

Topic 06

Diagnostic imaging, biopsy and staging

Featured Speakers — Cancer 2027

Browse all speakers →

Recent Research Presented at Cancer Sessions

Related Scientific Sessions at IPHC 2027

Why Attend the Cancer Conference 2027

Earn CPD Credit

Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.

Present Your Research

Oral and poster slots for original Cancer work, reviewed by the scientific committee.

Network Globally

Meet public health researchers, educators, and policy leaders from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Cancer research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join IPHC 2027 for the Cancer track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Cancer Conference 2027 — FAQs

What is the Cancer track at IPHC 2027?

The Cancer track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Cancer sessions?

Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Cancer are all welcome — whether presenting or attending.

Can I present my research in the Cancer track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Cancer sessions?

Yes. IPHC 2027 is a hybrid conference — attend the Cancer track in person in Singapore or join live online, with on-demand access afterward.

Join the IPHC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us